Altimmune Inc (ALT)
Altimmune Return on Equity (TTM)
Altimmune Inc Return on Equity (TTM) Chart
Altimmune Inc Historical Return on Equity (TTM) Data
| Data for this Date Range | |
|---|---|
| Dec. 31, 2018 | Upgrade |
| Sept. 30, 2018 | Upgrade |
| June 30, 2018 | Upgrade |
| March 31, 2018 | Upgrade |
| Dec. 31, 2017 | Upgrade |
| Sept. 30, 2017 | Upgrade |
| June 30, 2017 | Upgrade |
| March 31, 2017 | Upgrade |
| Dec. 31, 2016 | Upgrade |
| Sept. 30, 2016 | Upgrade |
| June 30, 2016 | Upgrade |
| March 31, 2016 | Upgrade |
| Dec. 31, 2015 | Upgrade |
| Sept. 30, 2015 | Upgrade |
| June 30, 2015 | Upgrade |
| March 31, 2015 | Upgrade |
| Dec. 31, 2014 | Upgrade |
| Sept. 30, 2014 | Upgrade |
| June 30, 2014 | Upgrade |
| March 31, 2014 | Upgrade |
| Dec. 31, 2013 | Upgrade |
| Sept. 30, 2013 | Upgrade |
| June 30, 2013 | Upgrade |
| March 31, 2013 | Upgrade |
| Dec. 31, 2012 | Upgrade |
| Sept. 30, 2012 | Upgrade |
| June 30, 2012 | Upgrade |
| March 31, 2012 | Upgrade |
| Dec. 31, 2011 | Upgrade |
| Sept. 30, 2011 | Upgrade |
| June 30, 2011 | Upgrade |
| March 31, 2011 | Upgrade |
| Dec. 31, 2010 | Upgrade |
| Sept. 30, 2010 | Upgrade |
| June 30, 2010 | Upgrade |
| March 31, 2010 | Upgrade |
| Dec. 31, 2009 | Upgrade |
| Sept. 30, 2009 | Upgrade |
| June 30, 2009 | Upgrade |
| March 31, 2009 | Upgrade |
| Dec. 31, 2008 | Upgrade |
| Sept. 30, 2008 | Upgrade |
| June 30, 2008 | Upgrade |
| March 31, 2008 | Upgrade |
| Dec. 31, 2007 | Upgrade |
| Sept. 30, 2007 | Upgrade |
| June 30, 2007 | Upgrade |
| March 31, 2007 | Upgrade |
| Dec. 31, 2006 | Upgrade |
| Sept. 30, 2006 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
View Return on Equity (TTM) for ALT
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
ALT Return on Equity (TTM) Benchmarks
| Benchmarks | |
|---|---|
| Bio-Path Holdings Inc | Upgrade |
| Seelos Therapeutics Inc | Upgrade |
| Pulmatrix Inc | Upgrade |
ALT Return on Equity (TTM) Range, Past 5 Years
| Minimum | Upgrade | Jun 2014 |
| Maximum | Upgrade | Dec 2015 |
| Average | Upgrade |
ALT Return on Equity (TTM) Excel Add-In Codes
- Metric Code: return_on_equity
- Latest data point: =YCP("ALT", "return_on_equity")
- Last 5 data points: =YCS("ALT", "return_on_equity", -4)
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
ALT News
Globe Newswire 04/11 09:27 ET
MT Newswires 04/04 22:47 ET
